Skip to content
OpenCapital
Get started

Idexx Laboratories IDXX Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Danaher logo
DanaherDHR
$1.2B+9.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$36.2M-12.3%
Agilent Technologies logo
Agilent TechnologiesA
$187M-1.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
$174M+0.6%
Veracyte logo
VeracyteVCYT
$4.35M-41.3%
Exagen Inc. logo
Exagen Inc.XGN
$1.26M+11.7%

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$41.53B+3.7%
Enterprise value$41.9B+3.3%
P/E37.9×-2.7×
P/S9.3×-0.6×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's operating lease liabilities (current)?
Idexx Laboratories (IDXX) reported operating lease liabilities (current) of $26.85M in Q1 2026.
How has Idexx Laboratories's operating lease liabilities (current) changed year-over-year?
Idexx Laboratories's operating lease liabilities (current) increased by 21.4% year-over-year, from $22.13M to $26.85M.
What is the long-term trend for Idexx Laboratories's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Idexx Laboratories's operating lease liabilities (current) has grown at a 8.8% compound annual growth rate (CAGR), from $17.73M to $27.07M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.